Works matching IS 10781552 AND DT 2024 AND VI 30 AND IP 8

Results: 23

The inpatient oncology pharmacist experience in the era of temporary oncologists.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1465, doi. 10.1177/10781552241287715

By:

Hayes, Sarah M;
Preedit, Justine

Publication type:

Article

Cellular therapy site-preparedness: Inpatient pharmacy implementation at a large academic medical center.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1442, doi. 10.1177/10781552241279025

By:

Martino, Janine G.;
McConnell, Kim;
Greathouse, Lorraine;
Rosario, Brent Del;
Jaskowiak, Jaclyn M.

Publication type:

Article

Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1437, doi. 10.1177/10781552241275205

By:

Trang, Dina;
Ngo, Dat;
Ali, Haris;
Tinajero, Jose

Publication type:

Article

Pembrolizumab related perforated appendicitis.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1455, doi. 10.1177/10781552241271026

By:

Kiracı, Murat;
Akturk Esen, Selin;
Turkay, Duriye Ozer;
Kos, Fahriye Tugba

Publication type:

Article

Incidence of hand-foot syndrome with protein kinase inhibitors in advanced hepatocellular carcinoma patients who received atezolizumab-bevacizumab combination.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1432, doi. 10.1177/10781552241269738

By:

Perrier, Marine;
Zuccaro, Emma;
Carlier, Claire;
Brugel, Mathias;
Slimano, Florian;
Bouché, Olivier

Publication type:

Article

Successful treatment of PD1-inhibitor induced psoriasiform dermatitis using IL-17 blockade without compromising immunotherapy efficacy.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1450, doi. 10.1177/10781552241269712

By:

Greene, Adina;
Penner, Scott;
Edmond, Amanda;
Camou, Monica;
Niu, Jiaxin;
Abbott, Jordan

Publication type:

Article

Dostarlimab: A promising new PD-1 inhibitor for cancer immunotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1411, doi. 10.1177/10781552241265058

By:

Farzeen, Zubaria;
Khan, Rana Rashad Mahmood;
Chaudhry, Ayoub Rashid;
Pervaiz, Muhammad;
Saeed, Zohaib;
Rasheed, Shahzad;
Shehzad, Behram;
Adnan, Ahmad;
Summer, Muhammad

Publication type:

Article

Polypharmacy and drug-drug interactions in metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1403, doi. 10.1177/10781552231218959

By:

Kapagan, Tanju;
Bulut, Nilufer;
Erdem, Gokmen Umut

Publication type:

Article

Safety outcomes of pembrolizumab with platinum agent chemotherapy combined with 5-fluorouracil or taxane derivative in head and neck cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1397, doi. 10.1177/10781552231217686

By:

Lee, Benjamin;
Chehab, Sarah S;
Fan, Wenyi;
Schell, Michael J;
Kirtane, Kedar S;
Shah, Anand B

Publication type:

Article

National survey of safe handling of hazardous drugs in hospital settings: Use of an innovative approach.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1385, doi. 10.1177/10781552231216101

By:

Pinet, Emma;
Langlais, Annie;
Chouinard, Audrey;
Bussières, Jean-François;
Tanguay, Cynthia

Publication type:

Article

Impact of telephone follow-up on hepatocellular carcinoma patients receiving oral chemotherapy from an ambulatory-care setting.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1378, doi. 10.1177/10781552231215427

By:

Sakata, Yukio;
Nomura, Hisanaga;
Nakajima, Hirofumi;
Kitajima, Tomomi;
Ito, Yukiko;
Yamamoto, Yoshiya

Publication type:

Article

Incidence of immune-related adverse events in U.S. veterans treated with immune checkpoint inhibitors.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1372, doi. 10.1177/10781552231214800

By:

Krall, Courtney;
Tague, Marshall;
Lund, Brian C

Publication type:

Article

Relative dose intensity of taxane-based chemotherapy in breast cancer patients in a tertiary hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1364, doi. 10.1177/10781552231214467

By:

Helwani, Amira M;
Al Suleimani, Yousuf M;
Al Baimani, Khalid;
Abdelrahman, Aly M

Publication type:

Article

Rapid drug desensitization to taxanes: a descriptive study from Turkey.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1358, doi. 10.1177/10781552231213318

By:

Yeşilkaya, Selma;
Aksu, Kurtuluş;
Vural Solak, Gürgün Tuğçe;
Demir, Şenay;
Topel, Musa;
Erçelebi, Dilek Çuhadar;
Koca Kalkan, İlkay;
Ateş, Hale;
Köycü Buhari, Gözde;
Nazik Bahçecioğlu, Sakine

Publication type:

Article

Outcomes of weight-based vs. fixed dose of Pembrolizumab among patients with non-small cell lung cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1352, doi. 10.1177/10781552231212926

By:

Chaitesipaseut, Lena;
Shah, Nina;
Truong, Thach-Giao;
Niu, Fang;
Shin, Patrick;
Sharma, Kavita;
Smith, Joshua;
Hui, Rita L

Publication type:

Article

Temporal effect of imatinib adherence on time to remission in chronic myeloid leukemia patients.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1343, doi. 10.1177/10781552231212207

By:

Clark, Samantha E.;
Marcum, Zachary A.;
Radich, Jerry;
Etzioni, Ruth;
Basu, Anirban

Publication type:

Article

Impact of relative dose intensity on pathologic complete response in human epidermal growth factor receptor 2 positive breast cancer patients receiving neoadjuvant TCHP.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1335, doi. 10.1177/10781552231212206

By:

Collette, Kaylyn;
Perkey, Cassandra L.;
Adams, Val;
Shelton, Brent J.;
Corum, Lauren S.;
Butts, Allison

Publication type:

Article

Optimizing antimicrobial prophylaxis strategies in acute leukemia patients: Assessing the efficacy of fluconazole.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1330, doi. 10.1177/10781552231212204

By:

Teran, Nicholas S.;
Park, Grace S.

Publication type:

Article

Patterns of prescription opioid use and opioid-related harms among adult patients with hematologic malignancies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1317, doi. 10.1177/10781552231210788

By:

Nabulsi, Nadia A;
Sharp, Lisa K;
Sweiss, Karen I;
Patel, Pritesh R;
Calip, Gregory S;
Lee, Todd A

Publication type:

Article

Development of oral oncolytic nonadherence estimator (ORACLE): A pretreatment nonadherence risk assessment for oral oncolytics.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1307, doi. 10.1177/10781552231208442

By:

Signorelli, Jessie;
Tran, Thuy;
Sirek, Marie E;
Díaz-Rohena, Yarelis;
Taraba, Jodi L;
Muluneh, Benyam;
Basu, Nayanika;
Lilly, Jennifer;
Darling, Julianne

Publication type:

Article

Assessment of adherence to routine vaccination schedules in oncology patients.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1302, doi. 10.1177/10781552231208434

By:

Sabatino, David C.;
Campbell, Peter;
Santamala, Jennifer

Publication type:

Article

Interleukin-6 as a biomarker of hypersensitivity reactions in chemotherapeutics and monoclonal antibodies.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1294, doi. 10.1177/10781552231204367

By:

Villarreal-González, Rosalaura V;
González-Díaz, Sandra;
Vidal-Gutiérrez, Oscar;
de la Cruz-de la Cruz, Carlos;
Pérez-Ibave, Diana C;
Garza-Rodríguez, María L

Publication type:

Article

Inclusion body myositis triggerred with long-term imatinib use.

Published in:

Journal of Oncology Pharmacy Practice, 2024, v. 30, n. 8, p. 1460, doi. 10.1177/10781552231168563

By:

Deniz, Rabia;
Güzelbey, Tevfik;
Narinoğlu, Sanem;
Şirin Kalem, Gizem;
Ekmen, Şevket Ali;
Gündoğdu Ünverengil, Gökçen;
Karaali, Zeynep

Publication type:

Article